Peptide-like compounds and their variants having immunomodulating activity including the N-terminal acylated and/or C-terminal amidated or esterified forms thereof of up to 60 amino acids wherein the peptide-type compound comprises the formula:

-

    • wherein:
      • and are the same or different and are of the formula:

        {R aa76-77 L}(aa79-84)(SEQ ID NO:1)   (a)

        or

        (aa84-79){L aa77-76 R}(SEQ ID NO:2)   (b)

    • wherein:
      • aa76 is E or V;
      • aa77 is D, S or N;
      • aa79 is R or G;
      • aa80 is I or N;
      • aa81 is a hydrophobic or small amino acid;
      • aa82 is R or L;
      • aa83 is G or R;
      • aa84 is a hydrophobic or small amino acid;
    • wherein
      • the sequence in the brackets may optionally be absent or truncated at any peptide type bond within the brackets may be used by themselves or in combination with immunosuppressant drugs, to reduce CTL activation, particularly in association with transplantation.
  •  
    Web www.patentalert.com

    < Physiologically active peptide and its use

    < Analogues of lipopolysaccharide-binding protein (LBP)-derived peptides that efficiently neutralize lipopolysaccharides (LPS)

    > Quality control for cytochemical assays

    > 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids

    ~ 00246